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Abstract
Background: Evaluating lymphocytic infiltration of minor salivary gland biopsy in primary Sjögren’s syndrome is
challenging. We developed and evaluated a digital method for quantifying B and T lymphocytes in whole minor
salivary gland biopsy slides.
Methods: Minor salivary gland biopsies were immunostained with anti-CD20/anti-CD3 antibodies using red/brown
chromogens. Slides were digitised and spliced into mosaics of smaller JPEG format images in which red and brown
pixels were counted. ImageJ Cell counter was used for validation. Agreement between the digital and manual
methods was evaluated using Bland-Altman plots and the interclass correlation coefficient. External validation relied
on the Chisholm-Mason, Tarpley, and focus-score methods.
Results: Of 62 minor salivary gland biopsy slides, 61.3 % had a Chisholm-Mason grade ≥ III or a focus score ≥1. The
number of pixels correlated well with manual cell counts (r = 0.95 for red pixels vs. B cell count and r = 0.91 for
brown pixels vs. T cell count). Interclass correlation coefficients between digital and manual counts were excellent
(0.92 for B/T cells). B-cell proportion showed a significant positive correlation with the focus score (Spearman’s
coefficient 0.463, p < 0.0001). Median B-cell proportion was lower in minor salivary gland biopsies with Chisholm
grades I–II (2.5 % (0.2–13.9)) than III–IV (30.0 % (15.5–45.2)) and increased with Tarpley’s class (1, 2.2 % (0.2–6.6); 2,
27.2 % (13.0–38.9); and 3–4, 48.5 % (29.4–56.4); p < 0.001 for all comparisons). Minor salivary gland biopsy B-cell
proportion was also significantly correlated with several markers of clinical and biological activity of the disease,
especially with markers of systemic B-cell hyperactivation.
Conclusion: The digital procedure proved accurate compared to the reference standard, producing reliable results
for whole tissue sections.
Trial registration: ClinicalTrials.gov [NCT00740948]. Registered 22 August 2008.
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Background
Primary Sjögren’s syndrome (pSS) is a common chronic
autoimmune disease characterised by lachrymal and sal-
ivary gland dysfunction due in part to lymphocytic infil-
tration and tissue destruction [1–5]. Ocular and oral
dryness combined with severe fatigue are the main
symptoms, and a significant proportion of patients have
extraglandular manifestations. The current reference
standard for diagnosing pSS is a specific pattern of focal
lymphocytic sialadenitis in labial minor salivary gland bi-
opsies (MSGBs), defined as the presence of one or more
dense aggregates of ≥50 lymphocytes adjacent to appar-
ently normal tissue [1, 6–9]. A focus score (FS) ≥1/
4 mm2 was established for classification and diagnosis
criteria [10].
Several other histological scores or grading systems
are also used to describe and evaluate glandular involve-
ment in pSS [11].
The cell subtypes and immune mediators relevant to
the pathophysiology of pSS have been identified [12–15].
The presence and number of the relevant cell subtypes
must be determined in MSGB infiltrates [16]. The
mononuclear infiltrates contain T cells, B cells, macro-
phages, interdigitating and follicular dendritic cells, and
natural killer cells. T and B cells predominate by far
among the inflammatory cells, and the proportion of B
cells increases with lesion severity and histopathological
scores [17]. The most advanced lesions contain tertiary
ectopic lymphoid structures, which may have germinal
centres [18–20].
Thus, detailed characterisation of the MSGB infiltrates
may be useful to classify patients into clinically relevant
subgroups. The presence of germinal centres has already
been proven to predict not only greater pSS severity, but
also the development of malignant lymphoma [20, 21].
Among infiltrate features, the number and/or proportion
of B cells may be of particular interest, for at least three
reasons. The proportion of B cells is highest in advanced
lesions and increases with histopathological scores, i.e.
mirrors disease severity. The B-cell burden within the
glands might influence the efficacy of anti-B-cell drugs
such as rituximab. Finally, as with peripheral B-cell
monitoring, B-cell monitoring in serial MSGBs might
improve patient management during follow-up.
No validated method for B- and T-cell quantification
suitable for use on an everyday basis is available. Many
studies relied on the Cell counter plugin of ImageJ soft-
ware (http://rsb.info.nih.gov/ij/plugins/cell-counter.html)
to count B and T cells [22–24]. This technique, although
very time consuming, can be considered the reference
standard for counting cells within a region of interest
[25]. However, no guidelines exist about the best method
for assessing cell-type proportions within lymphocytic
infiltrates. Recently introduced digital procedures allow
whole-slide scanning followed by software-based image
assessment. Standardisation is a major advantage of
these procedures. The availability of a standardised
method for evaluating lymphocytic infiltrate subtypes in
patients with pSS would be valuable, most notably for
monitoring treatment responses.
Our objective here was to design a digital procedure
for quantifying B and T cells within MSGB infiltrates in




The randomised multicentre TEARS trial (Tolerance
and Efficacy of Rituximab in primary Sjögren’s syn-
drome) was designed to evaluate the efficacy of rituxi-
mab in pSS [26]. It was approved by the appropriate
ethics committee (Comité de Protection des Personnes
Ouest VI), and all patients gave written informed con-
sent before study enrolment. The protocol was regis-
tered on ClinicalTrials.gov [NCT00740948]. All patients
fulfilled American European Study Group classification
criteria. MSGB was performed routinely during the
study at four of the 14 participating centres (Brest, Lille,
Nantes, and Rouen), and the 62 formalin-fixed paraffin-
embedded MSGBs thus obtained were sent to the coord-
inating centre in Brest.
Conventional MSGB evaluation
For each MSGB, a single pathologist specifically trained
in pSS recorded the histological findings into a centra-
lised database. Chisholm-Mason grades [1] were dichot-
omised as 0, I, and II (0+) vs. III and IV (1+). The
original version of Tarpley’s classification [27] was a 0 to
IV (4+) scale with class 0 indicating normal salivary tis-
sue and class IV (4+) a diffuse round-cell infiltrate with
fibrosis completely destroying the lobular architecture.
We used a previously published simplification into three
groups: SS-I, mild lesions, 1+; SS-II, intermediate le-
sions, 2+; and SS-III, severe lesions, 3+ and 4+ [17]. The
FS [8, 9] and germinal centre-like structures were
assessed as previously described [8, 11, 19, 27].
Double-staining immunohistochemistry with anti-CD3
and anti-CD20 antibodies was performed on 4-μm thick
tissue sections using the Benchmark XT® automated
slide preparation system (Roche Diagnostics, Meylan,
France), according to the manufacturer’s instructions.
After deparaffinisation and pre-treatment with cell con-
ditioner 1 (pH 8) for 8 minutes, immunostaining was
performed using anti-CD3 antibody (polyclonal rabbit
antibody, Dako, dilution 1/100, 32 minutes incubation at
37 °C) followed by revelation with a brown chromogen
using the ultraView Universal DAB Detection Kit® (Ven-
tana Medical Systems, Roche Diagnostics). The slides
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were heated at 95 °C for 8 minutes and the second im-
munostaining was performed using anti-CD20 antibody
(monoclonal mouse antibody, clone L26, Dako, dilution
1/100, 20 minutes incubation at 37 °C) with red-
chromogen revelation using ultraView Alkaline Phos-
phatase Red Detection Kit® (Ventana Medical Systems).
After washing and counterstaining with one drop of
haematoxylin for 12 minutes and one drop of blueing re-
agent for 4 minutes, the slides were removed from the
immunostainer, washed in water with dishwashing deter-
gent, and mounted.
Slide digitisation and conversion
For each MSGB, the stained tissue slide was digitised
using the NanoZoomer HT Scan system (Hamamatsu
Photonics, Hamamatsu, Japan; http://www.hamamatsu.
com/jp/en/index.html). Whole standard glass slides were
scanned at 20-fold magnification (0.46 μm/pixel). The
resulting virtual slides had a mean file size of 250 Mb
(NDPI format). Each NDPI slide image was spliced to
create a systematic mosaic of smaller JPEG images
(about 1200 × 800 pixels per image with 9–318 images
per gland and a mean of 42 images per gland), using Ha-
mamatsu NDP.view2 viewing software (Fig. 1). The
digital images covered the entire MSGB section. This
way of proceeding ensured that no overlap occurred
between the image fragments used to produce the
mosaic; this point constitutes an advantage over manual
acquisition.
Digital procedure
Two of the authors (SS and SC) developed a digital pro-
cedure to quantify pixels corresponding to B and T cells
in MSGBs. The source code, available on https://github.
com/dridk/bgsa-ndpi, was written using Python 2.7 and
licensed under GPL3. The same procedure was used to
analyse the spliced NDPI image of each MSGB slide
(Fig. 1). We used colour transformation to separate
brown areas (indicating T cell pixels) and red areas (indi-
cating B cell pixels). We used the YCbCr colour space,
an alternative method for encoding red/green/blue
(RGB) information that is well suited to JPEG format
images. YCbCr contains one channel for luminance (Y)
and two other channels for chrominance (blue and red).
The red channel was selected; then, brightness and con-
trast were adjusted to obtain a binary (black and white)
pattern in which red pixels were converted to black and
all other colour channels to white. For the brown areas,
we shifted hue and saturation into a different colour
space (100, 200, 50) to convert the brown colour to red,
which is more easily detected. We then applied the same
process used for red. A histogram function counted the
black pixels and white pixels. Thus, for each JPEG for-
mat image, we obtained the pixel counts for the red-
and brown-stained areas.
Fig. 1 The digital pixel counting procedure. a A minor salivary gland biopsy section on a standard glass slide was scanned using the NanoZoomer HT
Scan system. b The NDPI file thus obtained was divided into several JPEG format files, which restored the original image if reassembled. The JPEG
format files were managed by the algorythm (source code, available on https://github.com/dridk/bgsa-ndpi). c The signal in a given pixel
was partitioned using a linear unmixing algorithm with simple red/green/blue imagery
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Validation of the digital procedure using manual B-cell
and T-cell counts as the reference standard
We selected a panel of 31 JPEG format images with vari-
ous cell infiltrate densities (Fig. 2) and used the ImageJ
Cell counter plugin to count T and B cells in each. At
each click on a point of the image, a number whose
colour indicated the cell type was displayed; there was
one colour for T cells and another for B cells. The suc-
cessive numbers thus obtained were tallied automatic-
ally. For each of the 31 images, this process was
performed independently by two pathologists (AU and
SC). The software ensured that each cell was counted
only once and that all cells within a specified area were
counted. Cells could be marked and re-examined to
check that they were lymphocytes and not another cell
type or a background artefact, without altering the cell
count obtained so far.
Interclass correlation coefficients (ICCs) were com-
puted to compare the B-cell and T-cell counts obtained
by each pathologist. For each image and each cell type,
the mean of the two manual counts served as the refer-
ence standard for evaluating our digital procedure. We
recorded the time needed for the manual counts of each
JPEG format image.
For each JPEG format image, we assessed correlations
between manual B-cell count and red-pixel count and
between manual T-cell count and brown-pixel count.
We then converted the brown- and red-pixel counts
(crude data) into digital counts of B and T cells. We
summed the brown-pixel counts and the manual T-cell
counts for the 31 JPEG format images and divided the
first number by the second to obtain a coefficient of
multiplication. The same procedure was then used to
convert the red-pixel number into a digital B-cell count.
Variation of B-cell and T-cell proportions according to
histological examination
For each of the 62 MSGBs, we applied the digital pro-
cedure to each JPEG format image and then summed
the digital T- and B-cell counts from all images. We
then compared the whole-gland B- and T-cell digital
counts thus obtained to the Chisholm-Mason grade,
Tarpley class, and germinal-centre status.
Correlation linking proportion of B cells in MSGBs to
clinical and laboratory features of disease activity
To assess whether B-cell proportion as measured in
MSGBs using our digital procedure might prove useful
for monitoring patients with pSS, we assessed correla-
tions linking B-cell proportion to the following markers
for disease activity: oral dryness intensity as measured
on a visual analogue scale (VAS); Eular Sjögren’s Syn-
drome Disease Activity Index (ESSDAI) [28]; unstimu-
lated whole salivary flow; and biological markers for
systemic B-cell activity (serum levels of IgG, anti-SSA
antibodies, and kappa + lambda free-light chains mea-
sured using a commercial test (The Binding Site), ac-
cording to the manufacturer’s instructions).
A B
C D
Fig. 2 Micrographs of four JPEG format images showing the manual-count mask used by the ImageJ Cell counter. Stained B cells (in red) are marked
with a dark blue dot and stained T cells (in brown) with a light blue dot. a First JPEG format image. Manual B-/T-cell counts: 135/361 (investigator 1)
and 159/406 (investigator 2). Digital B-/T-cell count: 120/423. b Second JPEG format image. Manual B-/T-cell counts: 689/1067 (investigator 1) and
751/1089 (investigator 2). Digital B-/T-cell count: 532/1014. c Third JPEG-format image. Manual B-/T-cell count: 41/356 (investigator 1) and
50/426 (investigator 2). Digital B-/T-cell count: 36/410. d Fourth JPEG format image. Manual B-/T-cell counts: 469/860 (investigator 1) and
448/841 (investigator 2). Digital B-/T-cell count: 599/820
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Statistical analysis
We computed the ICCs to assess agreement between
manual and digital B- and T-cell counts. We also gener-
ated Bland and Altman plots with their limits of agree-
ment, defined as the mean of the differences ±1.96
standard deviations above and below the mean differ-
ence (known as the bias) [29]. With this method, about
95 % of normally distributed differences fall between the
limits of agreement. The two measurement methods are
considered equivalent if the difference between the high-
est and lowest limits of agreement is not clinically mean-
ingful. To evaluate associations linking B- and T-cell
proportions to histopathological parameters, we chose
the Mann–Whitney test, Kruskal-Wallis one-way ana-
lysis of variance, or Spearman’s correlation coefficient.
Statistical analyses were performed using R (www.r-
project.org) and GraphPad Prism (San Diego, CA, USA)
software. Values of p < 0.05 were considered significant.
Table 1 Validation and calibration of the digital procedure; 31 JPEG format files were chosen to represent several inflammatory
infiltrate densities
JPEG format image B cells (AU) B cells (SC) Red pixels T cells (AU) T cells (SC) Brown pixels
ST5/1/gland_26_5.jpg 10 10 2656 98 88 6863
ST5/1/gland_26_8.jpg 25 24 1778 112 114 5755
ST5/1/gland_26_10.jpg 161 154 30,292 209 183 9368
ST5/1/gland_26_13.jpg 50 53 10,363 201 184 8956
ST5/1/gland_26_18.jpg 116 102 19,832 325 293 22,583
ST5/1/gland_26_21.jpg 166 162 27,671 278 240 12,576
ST5/1/gland_49_18.jpg 151 137 27,109 512 485 25,954
ST5/1/gland_71_30.jpg 109 129 24,932 384 383 27,830
ST5/1/gland_71_47.jpg 135 159 34,795 361 406 42,367
ST5/1/gland_71_48.jpg 132 114 24,067 303 269 19,527
ST5/1/gland_71_54.jpg 110 115 38,737 165 145 23,610
ST5/1/gland_71_62.jpg 241 216 95,764 150 126 15,149
ST5/1/gland_71_65.jpg 288 284 108,027 260 242 33,111
ST5/1/gland_71_83.jpg 181 167 51,012 211 179 30,594
ST5/1/gland_86_0.jpg 235 211 106,218 401 408 52,289
ST5/1/gland_86_2.jpg 121 118 40,319 522 516 88,540
ST5/1/gland_86_3.jpg 469 448 171,921 860 841 81,997
ST5/1/gland_87_16.jpg 689 751 153,788 1067 1089 101,444
ST5/1/gland_87_24.jpg 41 50 10,413 356 426 41,090
ST5/1/gland_87_28.jpg 157 147 54,422 613 547 63,898
ST5/1/gland_87_29.jpg 57 77 19,191 274 297 29,548
ST5/1/gland_89_0.jpg 117 135 37,489 130 103 17,342
ST5/1/gland_89_1.jpg 0 0 89 29 29 3567
ST5/1/gland_89_2.jpg 153 154 39,934 198 170 22,261
ST5/1/gland_89_3.jpg 2 2 324 10 9 1115
ST5/1/gland_89_4.jpg 0 0 6 12 15 1075
ST5/1/gland_89_5.jpg 24 21 3310 135 113 15,717
ST5/1/gland_89_6.jpg 1 1 131 19 17 2194
ST5/1/gland_89_7.jpg 1 1 88 30 31 4321
ST5/1/gland_89_8.jpg 1 2 113 64 69 6119
ST5/1/gland_89_9.jpg 11 9 909 273 297 26,749
Mean 128 128 36,635 276 268 27,210
Median 116 115 24,932 211 184 22,261
Q1–Q3 18–159 16–156 2217–40,126.5 121–358.5 108–394.5 7910–31,852.5
The ImageJ Cell counter plugin was used to count B and T cells in each file. For each of the 31 images, the process was performed independently by two
pathologists (AU and SC). The third and the last columns indicate the number of pixels calculated with the digital procedure for B and T cells. Q
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Results
Details on the study population have previously been
published (in Table 1, group II in [30]). Of the 62
MSGBs, 38 (61.3 %) had a Chisholm-Mason grade > III
or a FS ≥1, 12 (19.3 %) contained germinal centres, 44
(71 %) had focal lymphocytic sialadenitis, 29 (46.8 %)
had signs of non-specific chronic sialadenitis, and 4
(6.4 %) appeared normal. In the simplified Tarpley classi-
fication, 25 (40.3 %) were SS-I, 22 (35.5 %) SS-II, and 15
(24.2 %) SS-III.
Validation and calibration of the digital procedure
Agreement between the two pathologists
The mean manual counts obtained independently by the
two pathologists (AU and SC) were 128 and 128, re-
spectively, for B cells, and 276 and 268, respectively, for
T cells (Table 1). The ICC was 0.99 (95 % confidence
interval (CI) 0.987–0.997) for both cell types. Discrepan-
cies were noted for dense infiltrates containing over 200
lymphocytes per JPEG format image. The reference
standard for assessing the accuracy of our digital proced-
ure was the mean of the counts obtained by the two
pathologists. Manual counting took approximately 15 mi-
nutes (range 6–30 minutes) per JPEG format image.
Agreement and calibration between the manual and digital
counts
Mean manual counts for the 31 JPEG images were
128 for B cells and 272 for T cells (Table 1). Mean
digital counts were 36,635 for red pixels (B cells) and
27,209 for brown pixels (T cells). Manual and digital
counts were closely correlated (Fig. 3). The factors
that converted the red- and brown-pixel counts to B-
and T-cell counts were 1/287 (128/36,635) and 1/100
(272/27,209), respectively. The ICC for manual and
digital counts was 0.92 (95 % CI 0.84–0.96) for both B
cells and T cells (p = 2.19 × 10−14 and p = 1.12 × 10−14, re-
spectively). The Bland-Altman plot (Fig. 3c) showed no
tendency to underestimate or overestimate cell counts
lower than 200. For counts greater than 200 cells, the soft-
ware tended to slightly overestimate the reference-
standard count. Figure 2 shows three examples of B-cell
and T-cell counts. Digital counting of the 31 JPEG format
images took 3 minutes. Analysis of the 2648 JPEG format
images for all 62 MSGBs took 180 minutes, yielding a
mean of less than 3 minutes per gland. For manual counts,
15 minutes were needed per JPEG format image, i.e.
648 hours for all 62 MSGBs. Some JPEG format images
contained no B or T cells or no gland parenchyma, as the
mosaics included peri-glandular adipose tissue and even
Fig. 3 Comparison of manual and digital counts. a Relations between the numbers of red and brown pixels and the manual counts of B and T cells,
respectively. b Bland-Altman plots of digital versus manual counts for 31 JPEG format images. There is no tendency to under- or overestimate counts
lower than 200 cells. With counts greater than 200 cells, our in-house software slightly overestimated the manual counts. SD Standard deviation
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empty areas. Nevertheless, manual counting was far more
time consuming.
Associations linking B cells, T cells, and infiltrate severity
The mean area of tissue was 5.9 mm2 (1–50 mm2) and
the median was 4 mm2. As B and T cells account for
over 90 % of all cells in lymphocytic infiltrates, we de-
fined the total lymphocytic infiltrate burden as the sum
of the B- and T-cell counts [17]. We therefore computed
the proportion of B cells as the B-cell count divided by
the sum of the B- and T-cell counts. The proportion of
B cells ranged from 0.01 % to 81 %; the median was
22.9 % (4.5–40.2). The proportion of T cells ranged from
18.9 % to 99.9 % with a median of 77.1 % (59.8–95.5).
The relative proportions of B and T cells varied with the
results of the histological parameters: B-cell proportions
were higher in glands with worse histological parameters
(Fig. 4). The proportion of B cells showed a significant
positive correlation with the FS (Spearman coefficient
0.463, p < 0.0001). When we compared glands with
Chisholm-Mason grades of I–II (n = 24) vs. III–IV (n =
38), we found that the median proportion of B cells was
2.5 % (0.2–13.9) vs. 30.0 % (15.5–45.2), respectively. The
comparison of glands in Tarpley class I (n = 23), II (n =
23), and III–IV (n = 16) showed median proportions of B
cells of 2.2 % (0.2–6.6), 27.2 % (13.0–38.9), and 48.5 %
(29.4–56.4), respectively. Glands with (n = 12) and with-
out (n = 50) germinal centres had median proportions of
B cells of 51.4 % (36.6–58.9) vs. 12.3 % (1.9–30.6) (p <
0.001 for all comparisons).
Associations linking proportion of B cells in salivary
glands to clinical and laboratory markers of disease
activity
The proportion of B cells in MSGBs correlated positively
with the oral dryness VAS score (Fig. 5a), the ESSDAI
(Fig. 5b), and laboratory markers of B-cell activity
(serum IgG, anti-SSA antibody, and kappa + lambda free
light chains levels (Fig. 5d, e, and f ). Conversely, the pro-
portion of B cells did not correlate with unstimulated
whole salivary flow (Fig. 5c).
Discussion
Our original digital cell pixel counting procedure proved
fast and reliable for determining B- and T-cell propor-
tion within salivary glands from patients with pSS. The
digital pixel count correlated well with the manual cell
count. The mean of red pixels was higher than the mean
of brown pixels. This result suggests that the red
chromogen has a larger area of staining or is more dis-
criminable by the algorithm than the brown chromogen.
This result was corrected by the conversion factor estab-
lished on the panel of 31 JPEG format images chosen to
represent several inflammatory infiltrate densities, in-
cluding areas with no inflammatory cells and areas with
high densities such as germinal centres.
Fig. 4 Association between proportion of B cells and infiltrate severity. The proportion of B cells (computed as B-cell count/(B-cell + T-cell count))
was related to four markers of infiltrate severity: Chisholm-Mason grade (a), focus score (b), presence of germinal centres (c), and Tarpley’s class
(d). The proportion of B cells varied significantly with the values of these severity markers (p < 0.0001)
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The digital counts correlated significantly with well-
established diagnostic and prognostic parameters such
as the FS and Tarpley’s class. Furthermore, the signifi-
cant correlations linking the digital counts to systemic
disease activity (ESSDAI) and biological markers (e.g.,
anti-SSA antibody) provided external validation of our
method. A major advantage of our digital procedure is
that it assesses the whole tissue section instead of a lim-
ited number of microscopic fields or a selected region of
interest. Manual cell counting was performed in most
studies by applying the ImageJ Cell counter to serial im-
ages taken using image-acquisition systems connected to
the microscope. Although these systems appear accurate,
their use is time consuming and can result in overlap
among images with some cells being counted more than
once. Automated systems are associated with less intra-
and inter-observer variability compared to manual
counting methods. They make the counting procedure
both less cumbersome and less subjective, thereby im-
proving reproducibility and precision [31, 32]. Finally,
developing an in-house procedure provides the oppor-
tunity to take into account and optimise all the factors
that may influence the staining process.
However, the limitations of digital methods stem from
the factors that affect assessments of the extent and in-
tensity of immunohistochemical staining in general
Fig. 5 Correlations linking proportion of B cells to clinical and laboratory markers for disease activity. The proportion of B cells within
minor salivary glands correlated with the intensity of oral dryness (visual analogue scale (VAS) score) (a), systemic activity (Eular Sjögren’s
Syndrome Disease Activity Index; ESSDAI) (b), and biological markers for B-cell activity (serum IgG, anti-SSA antibody, and free light chains
levels) (d, e, f), but not with unstimulated whole salivary flow (UWSF) (c)
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[30–34]. Staining can be influenced by transportation,
fixation, and sectioning of the specimen; antigen re-
trieval; staining protocols; and control reagents. A chal-
lenge to the accuracy of digital automated systems is
that the relation between the amount of antigen and
the intensity of the signal is not always linear [31, 33].
As a consequence, the signal on the slide may not be
strictly representative of the abundance of the antigen
in the tissue section. Difficulties may arise in separating
similar chromogens or different signals that overlap in
space. The optical signal from each chromogen must be
isolated to ensure accurate counting. When developing
our method, we experienced substantial difficulty in
separating brown from red using the RGB digital colour
space, due to overlap among the spectral profiles. We
therefore used a different digital colour format in the
RGB model (Hue-Saturation-Value), which improved
discrimination between red and brown. The RGB ap-
proach is less precise than multispectral analysis. Multi-
spectral cameras acquire stacks of images at multiple
wavelengths and allow the determination of precise op-
tical spectra for each pixel [33, 34]. However, multi-
spectral requires expensive equipment. Even though
powerful image analysis systems are emerging, which
also take into account morphology criteria, our results
suggest that pixel area quantification is strongly corre-
lated to manual count, histological and clinical factors.
Finally, we have shown that digital counting of stained
cells throughout an entire tissue section was accurate and
avoided the drawbacks of manual counting such as uncer-
tainties about the number of cells to be counted (e.g., 100,
200, 500, or 1000?) and where to count the cells (e.g., ger-
minal centres, sites of highest cell density, or sites of low-
est cell density?).
Conclusions
To our knowledge, we have designed the first pixel-
based method that uses the RGB approach to separately
count B and T cells in MSGBs from patients with pSS.
In addition to saving time, our method has the major
advantages of being standardised and automated. We
actually use it on a prospective research basis and wish
to validate it externally with other centres, given the
variation in staining methods, as some hospital clinical
laboratories may prepare tissues under different
conditions.
The increased accuracy of digital B- and T-cell counts
compared to manual counts may help to divide patients
with pSS into clinically relevant subgroups, thereby opti-
mising treatment decisions by improving the prediction
of long-term outcomes and treatment responses.
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